8-K: Scilex Sues Over Alleged $100M Securities Fraud

Scilex Holding Company has filed a lawsuit against Marc Wade, St. James Bank & Trust, Omega & Corinth Group, and Bank of New York Mellon Corporation, alleging securities fraud, fraudulent inducement, conversion, and negligence related to a non-recourse loan and the unauthorized sale of over 85 million Datavault AI shares.

Summary

• Scilex Holding Company (Scilex) filed a complaint in the U.S. District Court for the Central District of California against Marc Wade, The St. James Bank & Trust Company Ltd., Omega & Corinth Group Ltd. (collectively, the Wade Defendants), and Bank of New York Mellon Corporation (BNY Mellon).
• The lawsuit asserts five causes of action: federal securities fraud, state securities fraud, fraudulent inducement, unlawful conversion, and negligence (against BNY Mellon).
• Scilex alleges a conspiracy to defraud it out of tens of millions of dollars worth of securities pledged as collateral for a non-recourse loan agreement.
• In late 2025, St. James, through Marc Wade and Omega & Corinth, agreed to lend Scilex up to $100 million, with Scilex transferring over 85 million shares of Datavault AI, Inc. (DVLT) as collateral.
• Scilex claims the Wade Defendants never intended to retain the shares but planned to sell them immediately to fund the loan and profit from a 40% difference due to a 60% loan-to-value ratio.
• The complaint states that Scilex's DVLT shares were transferred to a brokerage account at BNY Mellon without authorization and subsequently sold off over approximately one month.
• The unauthorized sales allegedly drove down the market value of DVLT shares, harming Scilex's remaining holdings and leading St. James to accuse Scilex of manufactured defaults.
• Scilex was allegedly induced to pledge additional DVLT shares and pay fees to cure these purported defaults, which were caused by the defendants' manipulation of the stock.
• BNY Mellon is accused of acting with extreme recklessness by permitting a fraudulent account, facilitating high-volume trades without authorization, and failing to comply with SEC reporting requirements (Forms 13G, 4, and 13-H) and KYC/AML policies.
• Scilex seeks damages of at least $100 million, preand post-judgment interest, punitive damages, rescission of the Loan Agreement, disgorgement of profits, and attorneys' fees and costs.

Sentiment

Score: 1

Explanation: StockSavvy.ai views this as extremely negative. The filing details a major alleged fraud against Scilex, involving the loss of significant assets, stock manipulation, and substantial financial damages, leading to a large-scale lawsuit.

Negatives

• Scilex alleges it was defrauded out of over 85 million shares of Datavault AI, Inc. (DVLT) worth over $100 million at the time of transfer.
• The Wade Defendants allegedly sold the pledged securities immediately upon receipt, contrary to the loan agreement and Scilex's explicit instructions.
• The sales were purportedly used to fund the loan, meaning the loan was financed by Scilex's own assets, not external capital from the lender.
• Defendants allegedly manipulated DVLT's stock price through massive sales, causing a significant drop from $1.39 on December 16, 2025, to $0.65 by December 31, 2025, and $0.71 by February 27, 2026.
• The stock price manipulation led to 'manufactured defaults' under the loan agreement, forcing Scilex to pledge an additional 20,425,360 DVLT shares and pay $499,878 in forbearance and waiver fees.
• BNY Mellon is accused of facilitating the fraudulent scheme by allowing an unauthorized account to be opened in Scilex's name and processing millions of dollars in non-compliant, high-volume trades without proper due diligence or SEC reporting.
• Marc Wade and the other Wade Defendants have a documented history of similar fraudulent schemes, including against Fengyun Jiang (stock loan fraud), BTIG (market manipulation), and The Anthos Group (advertising services fraud).
• St. James Bank & Trust and Omega & Corinth Group have faced at least four similar lawsuits in the United Kingdom for liquidating collateral and denying early repayment requests.

Risks

• Significant financial loss for Scilex due to the alleged unauthorized sale of over 85 million Datavault AI shares and the associated decline in their market value.
• Reputational damage for Scilex due to involvement in a high-profile fraud case, potentially impacting investor confidence.
• Ongoing legal costs and resource allocation required to pursue the lawsuit against multiple defendants.
• Uncertainty regarding the recovery of damages or the pledged securities, as legal proceedings can be lengthy and outcomes are not guaranteed.
• Potential for further stock price volatility for Datavault AI, Inc. (DVLT) due to the alleged past manipulation and ongoing legal disclosures.
• Exposure to counterclaims or prolonged litigation from the defendants, particularly BNY Mellon, which could further drain company resources.

Future Outlook

The future outlook for Scilex is dominated by the ongoing legal proceedings. The company is seeking to recover at least $100 million in damages and the return of its Datavault AI shares. The outcome of this complex litigation will significantly impact Scilex's financial position and its holdings in Datavault AI. There is no guidance provided on operational or strategic business developments beyond the lawsuit.

Management Comments

• Henry Ji and Stephen Ma (Scilex CEO and COO/CFO) were introduced to Marc Wade as someone who could provide a non-recourse stock loan.
• Ji and Ma emphasized to Wade and Barlow that it was critical that any shares given as collateral not be sold, as Scilex believed in Datavault's long-term value and did not want to trigger onerous reporting obligations.
• Ji and Ma were told by Wade that he was an experienced and reliable financial professional who had done $6-7 billion worth of stock loan transactions in the past year for insurance companies, and that he owned St. James and Omega & Corinth.
• Wade reassured Ji that he had just received $10 billion from various insurance companies and had the funding to support Scilex in the future.
• Ma repeatedly asked St. James's COO, Anastacia Brooks, to send the purported $9,975,000 to Scilex's U.S. bank account, but she made excuses to delay the transfer.
• Ma asked Brooks for a statement showing where the Pledged Securities were being held and for online access to the Scilex accounts at St. James and Stark, but Brooks refused access and provided evasive answers.
• Ji expressed surprise and objected to the Trading Volume Default, recalling Wade's prior reassurance that he had never claimed such a default from a borrower.

Industry Context

StockSavvy.ai notes that this lawsuit highlights critical vulnerabilities in collateral management and the potential for sophisticated financial fraud within the lending and securities industries. The alleged scheme, involving the immediate liquidation of pledged collateral to fund a loan and manipulate stock prices, underscores the importance of robust due diligence, transparent custodial arrangements, and strict adherence to regulatory reporting requirements. The involvement of a major financial institution like BNY Mellon, even if allegedly reckless rather than complicit, raises concerns about the effectiveness of 'Know Your Customer' (KYC) and anti-money laundering (AML) controls in preventing illicit activities. This case could prompt increased scrutiny from regulators on broker-dealer responsibilities in verifying beneficial ownership and transaction legitimacy, particularly in complex cross-border loan and collateral arrangements.

Comparison to Industry Standards

• BNY Mellon allegedly failed to comply with industry standards and federal/state laws regarding KYC and AML requirements, specifically by not verifying the identity and authority of persons acting on behalf of Scilex, not obtaining adequate corporate authorization documents, and not confirming the account's legitimacy through independent channels.
• The alleged failure to file SEC Forms 13G, 4, and 13-H for high-volume trades of DVLT shares, despite Scilex being the single largest shareholder, represents a significant deviation from standard broker-dealer reporting obligations for substantial equity positions.
• BNY Mellon's alleged continued facilitation of millions of dollars in non-compliant trades, even after 'red flags' should have been raised by the volume and lack of reporting, falls short of the expected duty of care for a sophisticated global financial institution.
• The alleged conduct of the Wade Defendants, particularly Marc Wade's history of similar stock manipulation and loan fraud schemes (e.g., against Fengyun Jiang and BTIG), demonstrates a pattern of behavior far outside ethical and legal industry practices for financial professionals and lending institutions.

Legal Proceedings

• Scilex Holding Company filed a complaint against Marc Wade, The St. James Bank & Trust Company Ltd., Omega & Corinth Group Ltd., and Bank of New York Mellon Corporation.
• The complaint asserts federal securities fraud (against all defendants), state securities fraud (against Wade Defendants), fraudulent inducement (against Wade Defendants), unlawful conversion (against all defendants), and negligence (against BNY Mellon).
• Scilex alleges a conspiracy to defraud it out of over 85 million Datavault AI, Inc. (DVLT) shares pledged as collateral for a non-recourse loan.
• The lawsuit claims the Wade Defendants immediately sold the pledged shares, used the proceeds to fund the loan, manipulated DVLT's stock price, and manufactured defaults to extract additional collateral and fees from Scilex.
• BNY Mellon is accused of recklessly facilitating the fraud by allowing an unauthorized account, processing high-volume trades without proper authorization, and failing to comply with SEC reporting and KYC/AML regulations.
• Scilex is seeking at least $100 million in damages, preand post-judgment interest, punitive damages, rescission of the Loan Agreement, disgorgement of profits, and attorneys' fees and costs.
• The complaint includes a demand for a jury trial on all issues and causes of action triable by jury.

Stakeholder Impact

• Shareholders: Potential significant financial loss due to the alleged fraud and unauthorized sale of Datavault AI shares, offset by potential recovery through the lawsuit. Legal costs will impact profitability.
• Employees: Indirect impact from company resources being diverted to litigation, potential for uncertainty regarding company financial health.
• Customers: No direct impact mentioned, but general market perception of the company could be affected.
• Suppliers: No direct impact mentioned, but general market perception of the company could be affected.
• Creditors: The lawsuit's outcome could impact Scilex's financial stability and ability to meet future obligations, depending on the recovery of damages.

Next Steps

• Scilex will pursue its complaint in the United States District Court for the Central District of California, seeking damages, rescission, disgorgement, and punitive damages.
• The legal proceedings will involve discovery, potential motions, and ultimately a trial or settlement.
• Scilex will need to manage the ongoing legal costs and resources associated with this complex litigation.

Key Dates

Recommendation

The filing details a severe alleged fraud against Scilex, involving the unauthorized liquidation of over $100 million worth of pledged securities, stock manipulation, and manufactured defaults. This represents a massive financial blow and exposes the company to prolonged, costly litigation with an uncertain outcome. The allegations against a major financial institution like BNY Mellon, even if for negligence, underscore the complexity and potential for further negative developments. Given the magnitude of the alleged losses, the ongoing legal battle, and the significant uncertainty, a seasoned investor would likely recommend a strong sell to mitigate further risk.

Keywords

Securities fraud, Stock manipulation, Loan agreement, Collateral, Datavault AI, BNY Mellon, Scilex Holding Company, Conversion, Fraudulent inducement, Regulation FD, 8-K filing, Litigation